Document is current
Any future updates will be listed below
-
Authors
De Bruyn, Lauren https://orcid.org/0000-0002-5036-3403
Vander Perre, Sarah
Verbruggen, Sascha https://orcid.org/0000-0003-4866-9865
Joosten, Koen https://orcid.org/0000-0002-0504-2475
Van den Berghe, Greet https://orcid.org/0000-0002-5320-1362
Langouche, Lies https://orcid.org/0000-0002-8564-6809
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (G069421N, G069421N)
H2020 European Research Council (ERC-2023-ADG-101133276)
Methusalem program of the Flemish Government (METH/14/06, METH/14/06)
- License Information
-
More Information
Article History
Received: 13 January 2025
Accepted: 21 February 2025
First Online: 4 March 2025
Declarations
:
: This is a secondary analysis of the multicenter (Leuven, BE, Rotterdam, NL, Edmonton, CA) PEPaNIC randomized controlled trial (ClinicalTrials.gov NCT01536275, n = 1440). The institutional or national ethical review boards of the participating centers approved the study protocol. Written informed consent was obtained from the parents or legal guardians.
: Not applicable.
: All authors declare that there is no conflict of interest to report.
